Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 1
2007 5
2008 1
2009 2
2010 1
2011 9
2012 5
2013 5
2014 5
2015 7
2016 3
2017 4
2018 5
2019 9
2020 8
2021 9
2022 12
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Modern diagnostics and treatment of Merkel cell carcinoma.
Weilandt J, Peitsch WK. Weilandt J, et al. Among authors: peitsch wk. J Dtsch Dermatol Ges. 2023 Dec;21(12):1524-1546. doi: 10.1111/ddg.15214. Epub 2023 Oct 24. J Dtsch Dermatol Ges. 2023. PMID: 37875785
[Iatrogenes Kaposi-Sarkom unter Vedolizumab bei Colitis ulcerosa].
Weilandt J, Hoffmann V, Zahn A, Guski S, Mroß M, Peitsch WK. Weilandt J, et al. Among authors: peitsch wk. J Dtsch Dermatol Ges. 2023 Apr;21 Suppl 2:22-24. doi: 10.1111/ddg.15099_g. J Dtsch Dermatol Ges. 2023. PMID: 37099011 German. No abstract available.
Corrigendum: Treatment Satisfaction of Patients with Psoriasis.
Schaarschmidt ML, Kromer C, Herr R, Schmieder A, Goerdt S, Peitsch WK. Schaarschmidt ML, et al. Among authors: peitsch wk. Acta Derm Venereol. 2022 Dec 12;102:adv00832. doi: 10.2340/actadv.v102.5920. Acta Derm Venereol. 2022. PMID: 36510390 Free article. No abstract available.
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akçetin L, Kölblinger P, Hoellwerth M, Meissner M, Mengi G, Braun AD, Mengoni M, Dummer R, Mangana J, Sindrilaru MA, Radmann D, Hafner C, Freund J, Rappersberger K, Weihsengruber F, Meiss F, Reinhardt L, Meier F, Rainer B, Richtig E, Ressler JM, Höller C, Eigentler T, Amaral T, Peitsch WK, Hillen U, Harth W, Ziller F, Schatton K, Gambichler T, Susok L, Maul LV, Läubli H, Debus D, Weishaupt C, Börger S, Sievers K, Haferkamp S, Zenderowski V, Nguyen VA, Wanner M, Gutzmer R, Terheyden P, Kähler K, Emmert S, Thiem A, Sachse M, Gercken-Riedel S, Kaune KM, Thoms KM, Heinzerling L, Heppt MV, Tratzmiller S, Hoetzenecker W, Öllinger A, Steiner A, Peinhaupt T, Podda M, Schmid S, Wollina U, Biedermann T, Posch C. Schumann K, et al. Among authors: peitsch wk. J Eur Acad Dermatol Venereol. 2023 May;37(5):894-906. doi: 10.1111/jdv.18779. Epub 2022 Dec 12. J Eur Acad Dermatol Venereol. 2023. PMID: 36433688
95 results